Literature DB >> 9151321

Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease).

D N Palmer1, R D Jolly, H C van Mil, J Tyynelä, V J Westlake.   

Abstract

Since the discovery of mitochondrial ATP synthase subunit c storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease), it has been found that other hydrophobic proteins also accumulate in different forms. Costorage of subunit c of vacuolar ATPase is observed in "mnd/mnd" mice and in English Setters, Border Collies and Tibetan Terriers. A small amount is stored in the ovine disease and none in the human late-infantile disease. It is a storage body matrix component. An additional 8 kDa component immunoreactive to vacuolar ATPase subunit c antibodies is found in brain-derived storage bodies. The sphingolipid activator proteins, SAPs A and D, are stored in the human infantile disease and a form in Miniature Schnauzer dogs, but neither of the c subunits are. These results suggest two classes of NCL, the subunit c-storing diseases, related by a series of lesions in a subunit c-turnover pathway, and the SAP-storing diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151321     DOI: 10.1055/s-2007-973666

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  11 in total

1.  Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.

Authors:  Chi-Hui Tang; Je-Wook Lee; Michael G Galvez; Liliane Robillard; Sara E Mole; Harold A Chapman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

2.  Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6.

Authors:  M F Broom; C Zhou; J E Broom; K J Barwell; R D Jolly; D F Hill
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

Review 3.  Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.

Authors:  Martin L Katz; Eline Rustad; Grace O Robinson; Rebecca E H Whiting; Jeffrey T Student; Joan R Coates; Kristina Narfstrom
Journal:  Neurobiol Dis       Date:  2017-08-30       Impact factor: 5.996

4.  Accumulation of glial fibrillary acidic protein and histone H4 in brain storage bodies of Tibetan terriers with hereditary neuronal ceroid lipofuscinosis.

Authors:  M L Katz; D N Sanders; B P Mooney; Gary S Johnson
Journal:  J Inherit Metab Dis       Date:  2007-11-15       Impact factor: 4.982

5.  Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues.

Authors:  Claudia Heine; Jaana Tyynelä; Jonathan D Cooper; David N Palmer; Milan Elleder; Alfried Kohlschütter; Thomas Braulke
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

6.  Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis.

Authors:  Manfred J Oswald; David N Palmer; Graham W Kay; Karen J Barwell; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2008-06-25       Impact factor: 5.996

7.  Spectral properties and mechanisms that underlie autofluorescent accumulations in Batten disease.

Authors:  Sabrina S Seehafer; David A Pearce
Journal:  Biochem Biophys Res Commun       Date:  2009-02-25       Impact factor: 3.575

8.  Identification of membrane proteins by tandem mass spectrometry of protein ions.

Authors:  Joe Carroll; Matthew C Altman; Ian M Fearnley; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-24       Impact factor: 11.205

Review 9.  Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.

Authors:  Amanda L Getty; David A Pearce
Journal:  Cell Mol Life Sci       Date:  2010-08-01       Impact factor: 9.207

10.  Spectrum of ocular manifestations in CLN2-associated batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function.

Authors:  Anton Orlin; Dolan Sondhi; Matthew T Witmer; Matthew M Wessel; Jason G Mezey; Stephen M Kaminsky; Neil R Hackett; Kaleb Yohay; Barry Kosofsky; Mark M Souweidane; Michael G Kaplitt; Donald J D'Amico; Ronald G Crystal; Szilárd Kiss
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.